Animal models of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis

Drug Discovery Today: Disease Models

Volumn 4, Issue 3, 2007, Pages 99-104

  Hoffmann, Nadine ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; GARLIC EXTRACT; PLACEBO; VIRULENCE FACTOR;

ACETYLATION; ANIMAL MODEL; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOFILM; CYSTIC FIBROSIS; EXPERIMENTAL INFECTION; GENETIC VARIABILITY; GRAM NEGATIVE INFECTION; LUNG INFECTION; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REPRODUCIBILITY; REVIEW;

EID: 42149116919     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2007.11.008     Document Type: Review

References (42)

1. Bjarnsholt T., et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiol 151 (2005) 373-383
2. Bjarnsholt T., et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiol 151 (2005) 3873-3880
3. Blackwood L.L., and Pennington J.E. Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs. Infect. Immun. 32 (1981) 443-448
4. Boucher J.C., et al. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun. 65 (1997) 3838-3846
5. Bragonzi A., et al. Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiol 152 (2006) 3261-3269
6. Cash H.A., et al. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Resp. Dis. 119 (1979) 453-459
7. Coleman F.T., et al. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. PNAS 100 (2003) 1949-1954
8. Costerton J.W., et al. Bacterial biofilms: a common cause of persistent infections. Science 284 (1999) 1318-1322
9. D'Argenio D.A., et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Micribiol. 2 (2007) 512-533
10. Diggle S.P., et al. The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR. Mol. Micribiol. 50 (2003) 29-43
11. Guilbault C., et al. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab. Anim. 39 (2005) 336-352
12. Hentzer M., et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22 (2003) 3803-3815
13. Heurlier K., et al. Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int. J. Med. Microbiol. 296 (2006) 93-102
14. -/- mice. Antimicrob. Agents Chemother. 51 (2007) 3677-3687
15. Hoffmann N., et al. The role of alginate production and quorum sensing evaluated in a CF mouse model of chronic Pseudomonas aeruginosa lung infection. 18th Annual North American Cystic Fibrosis Conference. St. Louis, USA. Poster (2004)
16. Hoffmann N., et al. A novel mouse model of chronic P. aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73 (2005) 2504-2514
17. Hoffmann N., et al. Polymorphonuclear leukocytes are suppressed by quorum sensing in a CF-mouse model of chronic Pseudomonas aeruginosa lung infection. J. Cystic. Fibros. 4 (2005) 46
18. Høiby N. New insight into the pathogenesis and epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis. In: Goossens H., Peetermans W., and Struelens M. (Eds). Proceedings of the 4th Elzenveld Workshop on Infectious Diseases (2004), Bristol-Meyers Squibb
19. Høiby N., et al. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand. J. Resp. Dis. 58 (1977) 65-79
20. Høiby N., et al. Pseudomonas aeruginosa and the biofilm mode of growth. Microb. Infect. 3 (2001) 1-13
21. Jelsbak L., et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lung of cystic fibrosis patients. Infect. Immun. 75 (2007) 2214-2224
22. Johansen H.K. Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: experimental studies in animals. APMIS 104 (1996) 5-42
23. Johansen H.K.a.N.H. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47 (1992) 109-111
24. Lam J., et al. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28 (1980) 546-556
25. Lee B., et al. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J. Clin. Microbiol. (2005) 43
26. Lee V.T., et al. Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection. Infect. Immun. 73 (2005) 1695-1705
27. Mathee K., et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiol 145 (1999) 1349-1357
28. Munder A., et al. Pulmonary microbial infection in mice: comparison of different application methods and correlation of bacterial numbers and histopathology. Exp. Toxic Pathol. 54 (2002) 127-133
29. Pearson J.P., et al. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect. Immun. 68 (2000) 4331-4334
30. Pier G.B., et al. Role of alginate O-acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect. Immun. 69 (2001) 1895-1901
31. Scholte B.J., et al. Cellular and animal models of cystic fibrosis, tools for drug discovery. Drug Discov. Today: Dis. Models/Resp. Dis. 3 (2006) 251-259
32. Silo-Suh L., et al. Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase. J. Bacteriol. 187 (2005) 7561-7568
33. Smith E.E., et al. Genetic adaptation by Pseudomonas aeruginosa to the airway of cystic fibrosis patients. PNAS 103 (2006) 8487-8492
34. Song Z., et al. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection. J. Med. Microbiol. 52 (2003) 731-740
35. Tang H.B., et al. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64 (1996) 37-43
36. Van Delden C., et al. Starvation selection restores elastase and rhamnolipid production in a Pseudomonas aeruginosa quorum-sensing mutant. Infect. Immun. 66 (1998) 4499-4502
37. VanHeeckeren A.M., and Schluchter M.D. Murine models of chronic Pseudomonas aeruginosa lung infection. Lab. Anim. 36 (2002) 291-312
38. VanHeeckeren A.M., et al. Response to acute lung infection with mucoid pseudomonas aeruginosa in cystic fibrosis mice. Am. J. Respir. Crit. Care Med. 173 (2006) 288-296
39. Wu H., et al. Pseudomonas aeruginosa mutations in lasl and rhll quorum sensing systems result in milder chronic lung infection. Microbiol 147 (2001) 1105-1113
40. Wu H., et al. Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa. Microbiol 146 (2000) 2481-2493
41. Yu H., et al. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect. Immun. 66 (1998) 280-288
42. Yu H.W., and Head N.E. Persistent infections and immunity in cystic fibrosis. Front. Biosci. 7 (2002) D442-D457